Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-15 Sale |
2023-05-17 4:29 pm |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
640 | $83.15 | $53,214 | 39,491 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-08 4:56 pm |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
3,961 | $83.46 | $330,585 | 40,131 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:40 pm |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
27,813 | $85.13 | $2,367,716 | 69,092 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-02 Exercise |
2023-03-06 4:40 pm |
N/A 2032-01-03 |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
25,000 | $0 | 69,092 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 4:40 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
25,000 | $27.32 | 69,092 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-04 4:48 pm |
N/A 2033-01-03 |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
59,494 | $0 | 94,643 (Direct) |
View |
Ownership |
2022-02-07 4:11 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Khan Samina SVP, Chief Medical Officer |
0 | $0 | 115,249 (Direct) |
View |